Piper Sandler Initiates Coverage On Structure Therapeutics with Overweight Rating, Announces Price Target of $58
Portfolio Pulse from richadhand@benzinga.com
Piper Sandler analyst Yasmeen Rahimi has initiated coverage on Structure Therapeutics (NASDAQ:GPCR) with an Overweight rating and a price target of $58.
July 27, 2023 | 9:58 am
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Piper Sandler has initiated coverage on Structure Therapeutics with an Overweight rating and a price target of $58, which could positively impact the stock.
The initiation of coverage by Piper Sandler, a major financial institution, with an Overweight rating indicates a positive outlook for Structure Therapeutics. The price target of $58 also suggests a potential upside for the stock, which could attract investors and drive the stock price up in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100